ArticleCancer medicine2024

Feasibility of atezolizumab and bevacizumab combination regimens in patients with hepatocellular carcinoma and lung cancer taking direct oral anticoagulants.

Tasuku Nakabori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.